CY2269B1 - Bioadhesive solid dosage form - Google Patents

Bioadhesive solid dosage form

Info

Publication number
CY2269B1
CY2269B1 CY0200020A CY0200020A CY2269B1 CY 2269 B1 CY2269 B1 CY 2269B1 CY 0200020 A CY0200020 A CY 0200020A CY 0200020 A CY0200020 A CY 0200020A CY 2269 B1 CY2269 B1 CY 2269B1
Authority
CY
Cyprus
Prior art keywords
solid dosage
dosage form
dosage forms
bioadhesive
bioadhesive solid
Prior art date
Application number
CY0200020A
Other languages
English (en)
Inventor
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CY2269B1 publication Critical patent/CY2269B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY0200020A 1995-12-27 2002-04-25 Bioadhesive solid dosage form CY2269B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95203649 1995-12-27

Publications (1)

Publication Number Publication Date
CY2269B1 true CY2269B1 (en) 2003-07-04

Family

ID=8221021

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0200020A CY2269B1 (en) 1995-12-27 2002-04-25 Bioadhesive solid dosage form

Country Status (26)

Country Link
US (1) US6303147B1 (de)
EP (1) EP0869772B1 (de)
JP (1) JP4317264B2 (de)
KR (1) KR100459029B1 (de)
CN (1) CN1146401C (de)
AT (1) ATE206304T1 (de)
AU (1) AU713849B2 (de)
BR (1) BR9612291A (de)
CA (1) CA2232152C (de)
CY (1) CY2269B1 (de)
CZ (1) CZ298690B6 (de)
DE (1) DE69615704T2 (de)
DK (1) DK0869772T3 (de)
EA (1) EA000818B1 (de)
ES (1) ES2164940T3 (de)
HU (1) HU228350B1 (de)
IL (1) IL123636A (de)
NO (1) NO320015B1 (de)
NZ (1) NZ325844A (de)
PL (1) PL186278B1 (de)
PT (1) PT869772E (de)
SI (1) SI0869772T1 (de)
SK (1) SK283370B6 (de)
TR (1) TR199800894T2 (de)
WO (1) WO1997024109A1 (de)
ZA (1) ZA9610886B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080213378A1 (en) * 1998-10-01 2008-09-04 Elan Pharma International, Ltd. Nanoparticulate statin formulations and novel statin combinations
AU6283299A (en) * 1998-10-01 2000-04-17 Elan Pharma International Limited Controlled release nanoparticulate compositions
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US6428814B1 (en) * 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
PL198797B1 (pl) * 1999-03-31 2008-07-31 Janssen Pharmaceutica Nv Zastosowanie wstępnie żelowanej skrobi
US7503493B2 (en) * 1999-10-25 2009-03-17 Silverbrook Research Pty Ltd Method and system for digitizing freehand graphics with user-selected properties
US20040156872A1 (en) * 2000-05-18 2004-08-12 Elan Pharma International Ltd. Novel nimesulide compositions
US7198795B2 (en) 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
US8980334B2 (en) * 2001-02-28 2015-03-17 Axiomedic Ltd. Double-layered absorbable solid compositions for the topical treatment of oral mucosal disorders
ATE525061T1 (de) * 2001-02-28 2011-10-15 Axiomedic Ltd Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
FR2827517B1 (fr) * 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
US20030124196A1 (en) * 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
US20030083286A1 (en) * 2001-08-22 2003-05-01 Ching-Leou Teng Bioadhesive compositions and methods for enhanced intestinal drug absorption
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US7846478B2 (en) * 2002-01-31 2010-12-07 Henkel Ag & Co. Kgaa Bioadhesive composition
DK1471887T3 (da) 2002-02-04 2010-06-07 Elan Pharma Int Ltd Nanopartikelkompositioner der har lysozym som overfladestabiliseringsmiddel
EP2283864A1 (de) * 2002-07-16 2011-02-16 Elan Pharma International Ltd. Flüssige Zusammensetzung enthaltend stabilisierte Wirkstoff-Nanopartikeln
MY142204A (en) 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
WO2005032554A1 (en) 2003-10-03 2005-04-14 Astron Research Pvt. Ltd A novel transmucosal delivery system
WO2005067887A2 (en) * 2004-03-24 2005-07-28 Actavis Group Formulations of ramipril
NZ551336A (en) * 2004-04-22 2010-04-30 Acucort Ab Pharmaceutical compositions for acute glucocorticoid therapy
TWI338583B (en) * 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
EA201001086A1 (ru) 2004-08-13 2011-10-31 Бёрингер Ингельхайм Интернациональ Гмбх Композиция пеллеты пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
US20070048369A1 (en) * 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US8349120B2 (en) * 2006-03-07 2013-01-08 Ora Health Corporation Multi-layer patch made on a sheet and enclosed in a blister
EP1837020A1 (de) 2006-03-24 2007-09-26 Bioalliance Pharma Bioadhäsive Schleimhautträger zur langsamen Verabreichung von aktiven Substanzen
US20070248655A1 (en) * 2006-04-21 2007-10-25 Haley Jeffrey T Lenticular shaped protective mouth sore discs
KR101474871B1 (ko) * 2006-05-23 2014-12-19 오라헬쓰 코포레이션 아카시아 껌 접착제를 갖는 2층 구강 접착 정제
US20070293587A1 (en) * 2006-05-23 2007-12-20 Haley Jeffrey T Combating sinus, throat, and blood infections with xylitol delivered in the mouth
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
WO2008007098A2 (en) * 2006-07-12 2008-01-17 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
US8974825B2 (en) * 2007-07-06 2015-03-10 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
EP3620153A1 (de) 2007-07-06 2020-03-11 Lupin Limited Pharmazeutische zusammensetzungen zur wirkstoffverabreichung im magen-darm-trakt
US20120027855A1 (en) 2007-07-06 2012-02-02 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
EP2163240A1 (de) * 2008-09-12 2010-03-17 Universita' Degli Studi Di Genova Verfahren zur Herstellung von bioadhesiven Kompaktmatrizen
WO2012087966A2 (en) 2010-12-20 2012-06-28 E. I. Du Pont De Nemours And Company Targeted perhydrolases
MX370175B (es) * 2013-03-06 2019-12-04 Novartis Ag Formulaciones de compuestos orgánicos.
CN105193768A (zh) * 2015-08-27 2015-12-30 武汉武药科技有限公司 一种曲安奈德口腔粘贴片及其制备工艺
EP3484486B9 (de) * 2016-07-15 2023-11-01 H2 Water Technologies Ltd Zusammensetzung zur herstellung von wasserstoffreichem wasser
US12133918B2 (en) 2021-10-01 2024-11-05 Griffin Gamma, Llc Partially pre-gelatinized cassava starch as pharmaceutical excipient

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3554764A (en) * 1967-12-21 1971-01-12 Gen Foods Corp Freeze-thaw resistant flour and starch thickener blend
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
EP0451433B1 (de) * 1990-04-12 1996-10-23 Janssen Pharmaceutica N.V. Zusammensetzung zur Anwendung eines Arzneimittels, bestehend aus einem Bioadhäsiven Trägerstoff mit verzögerter Freisetzung
US5330761A (en) * 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5370878A (en) 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
TW355683B (en) 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5656283A (en) 1995-06-08 1997-08-12 Ortho Pharmaceutical Corporation In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product

Also Published As

Publication number Publication date
CZ298690B6 (cs) 2007-12-27
AU713849B2 (en) 1999-12-09
TR199800894T2 (xx) 1998-08-21
ATE206304T1 (de) 2001-10-15
NO981027L (no) 1998-06-15
DE69615704D1 (de) 2001-11-08
ES2164940T3 (es) 2002-03-01
US6303147B1 (en) 2001-10-16
KR19990067112A (ko) 1999-08-16
JP4317264B2 (ja) 2009-08-19
AU1308597A (en) 1997-07-28
ZA9610886B (en) 1998-06-23
DK0869772T3 (da) 2002-01-21
EP0869772A1 (de) 1998-10-14
SK88798A3 (en) 1998-11-04
JP2000502691A (ja) 2000-03-07
BR9612291A (pt) 1999-07-13
WO1997024109A1 (en) 1997-07-10
EA000818B1 (ru) 2000-04-24
CZ199298A3 (cs) 1998-09-16
NO981027D0 (no) 1998-03-09
PL326196A1 (en) 1998-08-31
SK283370B6 (sk) 2003-06-03
HUP9802913A3 (en) 2000-06-28
IL123636A (en) 2001-04-30
EA199800350A1 (ru) 1998-10-29
IL123636A0 (en) 1998-10-30
KR100459029B1 (ko) 2006-03-27
NO320015B1 (no) 2005-10-10
CN1146401C (zh) 2004-04-21
PT869772E (pt) 2002-03-28
EP0869772B1 (de) 2001-10-04
HU228350B1 (hu) 2013-03-28
HUP9802913A2 (hu) 1999-06-28
DE69615704T2 (de) 2002-07-11
PL186278B1 (pl) 2003-12-31
CA2232152A1 (en) 1997-07-10
CA2232152C (en) 2007-02-06
SI0869772T1 (en) 2002-04-30
CN1200667A (zh) 1998-12-02
HK1015680A1 (en) 1999-10-22
NZ325844A (en) 1999-06-29

Similar Documents

Publication Publication Date Title
IL123636A0 (en) Bioadhesive solid dosage form
BG105857A (en) Pregelatinized starch in a controlled release formulation
CA2159580A1 (en) Pharmaceutical Compositions Containing Polyvinylpyrrolidone and a Tri-Ester and Process of Manufacture Thereof
MY118371A (en) Tetrahydrolipstatin containing compositions
CA2445519A1 (en) Method for manufacturing a low dose pharmaceutical composition
MY125662A (en) Pharmaceutical formulations containing darifenacin
CA2227887A1 (en) Pharmaceutical compositions of conjugated estrogens and methods for their use
CA2238271A1 (en) Pharmaceutical compositions comprising flurbiprofen
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
CA2214026A1 (en) Pharmaceutical compositions comprising monoamine oxidase b inhibitors
AU3846901A (en) Oral, nasal and pulmonary dosage formualtions of copolymer 1
FR2698788B1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
NZ510563A (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
CA2330480A1 (en) Controlled release formulation of divalproex sodium
TNSN04048A1 (en) Dosage regimen and pharmaceutical composition for emergency contraception
PL336658A1 (en) Stabilised tilbone compositions
CA2318260A1 (en) Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
AP1485A (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin.
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
RU2449796C9 (ru) Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
ES2059260A1 (es) Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
HK1041475A1 (zh) L-dopa乙酯的制备方法